Illness Perception and Quality of Life in Colorectal Cancer With Ascites
Impact of Illness Perception on Quality of Life in Patients With Colorectal Cancer and Ascites
1 other identifier
observational
218
1 country
1
Brief Summary
This study aimed to investigate the impact of illness perception on the quality of life (QoL) in patients diagnosed with colorectal cancer (CRC) complicated by ascites. The study explores how patients' cognitive and emotional beliefs about their illness relate to their physical, psychological, and social well-being.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
April 30, 2025
CompletedFirst Submitted
Initial submission to the registry
July 1, 2025
CompletedFirst Posted
Study publicly available on registry
July 10, 2025
CompletedJuly 10, 2025
July 1, 2025
1.3 years
July 1, 2025
July 1, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Quality of Life Score
Assessed using the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (EORTC QLQ-C30, version 3.0). This 30-item questionnaire evaluates global health status, five functional scales (physical, role, emotional, cognitive, social), and symptom scales. All scores are transformed to a 0-100 scale. For functional scales and global QoL, higher scores represent better functioning or QoL.
Assessed once per participant during the study period from January 2024 to April 2025
Illness Perception Score
Assessed using the Brief Illness Perception Questionnaire (BIPQ). This 8-item questionnaire evaluates cognitive and emotional representations of illness on a 0-10 scale. The total score ranges from 0 to 80, with higher scores indicating a more threatening or negative illness perception after reverse-scoring relevant items.
Assessed once per participant during the study period from January 2024 to April 2025
Study Arms (1)
Patients with Colorectal Cancer and Ascites
A single cohort of 218 patients with a confirmed diagnosis of colorectal cancer and concomitant ascites. These patients were treated at the Hebei Provincial Hospital of Traditional Chinese Medicine between January 2024 and April 2025. Data on their clinical characteristics, illness perceptions, and quality of life were collected at a single point in time for this cross-sectional analysis.
Eligibility Criteria
The study population included patients diagnosed with colorectal cancer and concomitant ascites. Participants were recruited from those treated at the Hebei Provincial Hospital of Traditional Chinese Medicine between January 2024 and April 2025. All consecutive patients who met the specific inclusion and exclusion criteria during this period and provided informed consent were enrolled in this cross-sectional study.
You may qualify if:
- Confirmed diagnosis of colorectal cancer with ascites, verified by imaging and pathological examination.
- Patient and/or legal guardian provided informed consent.
- Karnofsky Performance Status (KPS) score ≥50.
- Estimated survival ≥6 months.
You may not qualify if:
- Presence of other active malignant tumors.
- Severe physical disability precluding participation.
- Severe cardiac, hepatic, or renal dysfunction not related to CRC.
- Presence of severe psychiatric or cognitive disorders.
- History of alcohol or drug addiction.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hebei Provincial Hospital of Traditional Chinese Medicine
Shijiazhuang, Hebei, 050000, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CROSSOVER
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 3 Months
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
July 1, 2025
First Posted
July 10, 2025
Study Start
January 1, 2024
Primary Completion
April 30, 2025
Study Completion
April 30, 2025
Last Updated
July 10, 2025
Record last verified: 2025-07